Drug Today Medical Times for the Clinical Trial Analytics Industry

Drug Today Medical Times of India Network
The clinical trials services industry is under pressure of twin dimension– cost control and accelerating demand for faster drug development. CEO of Cytel India sees this major challenge as an opportunity for professionals. According to him, his company has launched with a view to bridge the yawning gap in talent availability.

Advances in Genomics, Personalized Medicine, and Risk-based Monitoring will spur increased investment in technology and innovation in services. CEO anticipates that India (and more generally Asia) with its large pool of young, talented human resource, will spearhead the growth of this segment.

The analytics assignments are undertaken by CROs who possess the expertise and capacity to conduct the data analytics work on the data that has been generated during clinical trials.

The pioneering courses offered by the organization square measure Clinical SAS® programming and Clinical SAS® place. The previous aims at providing in depth coaching in SAS® with Associate in nursing orientation to the Clinical Trials Domain. The latter may be a course that provides sensible expertise that closely resembles the assignments entry level SAS® professional’s square measure needed to undertake.
The next course on offer is a strategic response of Cytel to address its growing demand for skilled SAS^® professionals. With a view to meet the requirement of the industry for significant work experience among the pool of aspiring professionals.

The candidates get trained for first six months on various topics which form the building blocks of Clinical Trial Services. The topics range from domain overview and data standards to therapeutic areas and statistics in clinical trials providing an unmatched exposure to the value chain of the industry.

During consequent twelve months they endure rigorous on-the-job coaching that exposes them to assignments that go nighest to the period work they're expected to perform as regular professionals. The candidates rising from this schedule are well-equipped with the theoretical coaching, sensible expertise and sound domain data.

The eligibility criterion is kind of versatile with ability and perspective being the foremost important pre-requisites. The programme is hospitable graduates and post-graduates from a spread of career streams– Life Sciences, Pharmacy, Biotechnology, Statistics, Engineering and applied science.

The latest providing is C-STAR (Clinical SAS® coaching and project-Readiness). This programme bundles the basic building blocks of skilled coaching (SAS® coaching and internship) and augments them by adding what are termed as differentiators among the aspirants – Domain data and Soft-skills. This seven-month programme is good for candidates United Nations agency would like to hitch as junior SAS® programmers within the run Services trade.

SAS and every one different SAS Institute INC. product or service names are registered emblems or emblems of SAS Institute INC. within the USA and different countries. ® indicates USA registration.

Drug Today Medical Times, A complete health based newspaper, A to Z medicine in India, Indian Health and medicine, Medical and pharma jobs, Private Hospital Vacancies, search for current job vacancies in Healthcare hospitals, healthcare management jobs, Physician Jobs, Medical Jobs, Healthcare management jobs and career advice, Nursing Jobs, Drug Today medical Times is the best health and medical advertisement company http://www.drugtodayonline.com/

No case reported, yet Tripura on swine flu vigil

http://www.drugtodayonline.com/

Drug Today Medical Times of India
This can serve as a guide for other states. Even as no case of swine flu reported from anywhere in Tripura the state Government does not want to take chances. Hence, state Health department has taken precautionary measures to ward off any outbreak.

State Health Minister Badal Chowdhury said, "No swine flu patient is found in the state so far. But the administration has decided to keep a vigil and monitoring inflow of visitors from outside especially people coming from states like Delhi, West Bengal etc."

For observation, two medical teams have been deputed at Agartala airport and Churai Bari. If any person is found suffering from this disease, he/she can be quarantined. Doctors and paramedical staffs are being trained to treat swine flu patients, in case of any eventuality, by the state Health Department. JB Hospital at Agartala has been named nodal hospital for the Treatment of Swine Flu,  Drug Today Medical Times, Treatment of Swine Flu, Health and Medicine in India- http://www.drugtodayonline.com/

Alternate source of energy- Future of the World

Drug Today Medical Times

Drug Today Medical Times
India is a developing country with huge population. This means that the requirement for energy and energy consumption both are high. In order to maintain the huge demand of the population it is vital to look for alternate source of energy which can sustain in long run.

As we all know that conventional source of energy which is currently being used for huge generation of electricity and power is only limited.  Hence, it is need of the hour to bring into focus alternate source of energy.

Alternate source of energy is defined as energy which is provided to us by nature and is freely available. This includes wind, water, earth, tidal and most importantly sun. While conventional source of energy is limited in nature and is produced after several years. These include coal, petroleum and electricity.
There are several benefits of exploring alternate source of energy firstly it is available free of cost to us and secondly it is pollution free. We all know that our climate is undergoing continuous changes thanks to global warming.

The major contributor to increased pollution and temperature of the earth is conventional source of energy. The burning of coal and petroleum produces several harmful gases like carbon dioxide, carbon monoxide, nitrous oxide and sulphur dioxide. These are very harmful gases which are leading cause of major respiratory diseases.

Apart from diseases, these have also led to depletion of ozone layer, which is a protective layer that protects our earth from the harmful radiations of the sun. Due to this depletion there has been increase in the cases skin cancer.

Therefore, this is high time that we put our resources in the right direction with renewable sources of energy. Our country has understood the importance and is already working on it. There is a Ministry of New and Renewable Source of Energy in Delhi which is centre for advance technology and research in the field of non-conventional sources of energy.

The Ministry has worked in setting up solar panels, solar water heaters, solar cookers utilising the energy of the sun and most recently Hydro electric car which runs on hydrogen and electricity to give power to its engine. In addition there is geothermal energy, wind energy and tidal energy.

So, if we want to save our planet, it is necessary to open up to alternate source of energy which is the future of world energy requirement.

A Complete Health based newspaper in India-  http://www.drugtodayonline.com/

Better Life Possible With Liver Cirrhosis- Drug Today Medical Times | PRLog

Better Life Possible With Liver Cirrhosis- Drug Today Medical Times | PRLog

Tax sops likely on life-saving devices and equipment

Drug Today
The Government appears to be serious to provide big push to the Indian Medical Devices and Equipment Sector. The push is expected to come with the recommendations of a task force constituted by the Government recently to look into difficulties faced in domestic manufacturing of medical devices.

 Pharmaceuticals Secretary has assured that the recommendations would come with two months.
“There are a lot of tariff barriers and it has become very easy to import world class equipment because materials are not available here, any equipment comes here to save a life of a human being we give all tax concessions,” said VK Subburaj, Secretary, Department of Pharmaceuticals.

The Indian Medical Devices and Equipment industry, valued at $5 billion, contributes considerably to India’s $60 billion healthcare sector. Moreover, it is growing at a faster annual rate of 15 per cent than 10-12 per cent growth seen in the healthcare sector in its entirety. A rise in the number of hospitals and the increased requirement for healthcare facilities creates a need for sophisticated devices and equipment, which can provide accurate treatment to individuals.

 However, low penetration, accessibility, affordability, awareness, nascent regulatory environment, low indigenous manufacturing, no distinct status of the industry, complex rules and guidelines and high capital requirement are key challenges, the industry is facing.

 “We have recently formed a task force, we are discussing all issues affecting the growth of this sector, the recommendations will be coming in another two months’ time,” Subburaj, Secretary, said recently at an Assocham Summit. The Task Force that includes stakeholders including Commerce Ministry, DIPP, Health and family welfare Ministry and all associated industries is chaired by the Pharmaceuticals Secretary.

 Senior officials and industry representative feel that ‘Make in India’ policy can provide the much needed push to this sector. The Government is expected to develop a regulatory structure leading to quality products being developed by manufacturers. The last few years have seen an increase in domestic manufacturing of medical equipment. With impetus from the government India is beginning to look forward to being recognized as a manufacturing destination for sophisticated medical technology.
 “We will look at modalities to see that these recommendations are implemented and a conducive atmosphere is created for medical devices manufacturing in India as today it is not conducive that is why the growth is very low,” said  the Secretary.
 “Today we are leaders in pharma sector as we are exporting drugs to 220 countries, it is a proud moment but in medical devices sector we cannot say so as we are almost at the lowest level, our coverage is only about one per cent which has to grow to at least about 10 per cent,” he added.

 The Government urgently needs to rationalise the tax structure if it wants to see India develops in this sector. Currently more than 90 per cent of medical devices and equipment are imported into India and only a small quantity of low profile items are manufactured in the country.

 The Association of Indian Medical Device Industry (AIMED) has suggested inter-ministry co-ordination to deal with complex multiple issues and diverse technologies for enabling indigenous manufacturing of medical devices and equipment in India.
                                                                                                                                                                                                    Drug Drug Today Medical Times of India
                                                                                                                                                                      http://www.drugtodayonline.com/